USSTOCK.TODAY
Pre-Market
Log in Sign up
🏛️
Trading Halted Since 2026-07-29: Trading has been halted. It may resume, and prices shown reflect the last trading day. The description below is for reference only.
Company overview

What Does Wellgistics Health ($WGRX) Do? — Stock Outlook, Earnings, Market Cap, Related Stocks, and Headquarters at a Glance

Updated April 23, 2026

A US healthcare holding company combining pharmaceutical wholesale, community pharmacies, and a blockchain-based PharmacyChain platform. The vertically integrated model and tech theme are attractive, but persistent net losses and ultra-low liquidity risks are significant.

Briefs · earnings · signals, first Subscribe

🏢 What does Wellgistics Health do?

Wellgistics Health (WGRX) is a healthcare holding company founded in 2022. It brings together pharmaceutical distribution, pharmacy operations, and prescription technology to strengthen the connection between independent pharmacies and drug manufacturers.

The company built its current structure through a series of acquisitions. The August 2024 acquisition of Wellgistics LLC added the pharmaceutical wholesale business, and the acquisition of Wood Sage brought in the pharmacy technology hub (APS) and community specialty pharmacy (CSP) operations.

💰 How does it make money?

Business SegmentRevenue WeightDescription
Pharmaceutical WholesaleCoreDistribution of prescription drugs to independent pharmacy networks
Community Specialty Pharmacy (CSP)CoreDispensing services for local communities
Technology Platform (PharmacyChain, etc.)GrowthSaaS fees from prescription transmission and clinic services
Manufacturer ServicesEmergingContract services such as patient care coordination and prior authorization

Trailing 12-month revenue is approximately $18.1 million, with a net loss of around $6.9 million. Wholesale makes up the bulk of revenue, while the technology platform is still in its early stages, so converting that into recurring SaaS revenue is the key task for improving profitability.

📐 Market Cap and Company Scale

Market cap stands at $9.3M, which is about About 0% the size of Samsung Electronics' market cap. The company employs - people.

This is a very small micro-cap healthcare name, and its stock tends to react sharply to blockchain and prescription-technology headlines. In October 2024, the stock jumped more than 160% in a single day on the announcement of the PharmacyChain blockchain integration.

📈 Wellgistics Health Outlook and Price Action

1-Year Price Performance
Analyst Consensus
No analyst coverage
Small-cap or newly listed stocks may not have valuation data collected.
52-Week Price Range
$4
Low $2 High $98
vs. low +41.66% vs. high -96.39%

The outlook hinges on the stability of wholesale and pharmacy revenue and the speed at which the technology platform is monetized. Wholesale and pharmacy operations are low-margin relative to their revenue scale, so on their own, profitability is limited. Accordingly, the company is trying to shift its margin profile by generating recurring revenue from SaaS platforms like PharmacyChain.

If it can accumulate contracts in higher-margin areas such as blockchain-based prescription tracking and patient-care services for drug manufacturers, there is room for a re-rating, but the business is still at an early stage, so execution needs to be validated.

⚔️ Key Strengths and Risks

The vertically integrated model combining wholesale, pharmacy, and technology is appealing, but the company is small and the pace of monetization for the technology business is uncertain.

💪 Key Strengths

Vertically Integrated Model
Combines wholesale, pharmacy, and technology platform under one holding company, capturing data and prescription flows in a single pipeline.
Independent Pharmacy Network
Holds a differentiated distribution channel focused on independent pharmacies, setting it apart from chain pharmacies.
Blockchain Technology Theme
Prescription-tracking technology like PharmacyChain can serve as a theme that draws market attention.
M&A-Driven Growth
Has built its portfolio quickly through multiple acquisitions.

⚠️ Key Risks

Persistent Net Losses
On a trailing 12-month basis, the company is posting net losses, so a path to profitability will take time.
Competition From Major Wholesalers
Large wholesalers such as Cencora, McKesson, and Cardinal Health dominate the market.
Slower-Than-Expected Tech Monetization
SaaS and blockchain services may not translate into revenue as quickly as hoped.
Funding and Dilution
Likely to require repeated capital raises to fund growth investments.
Ultra-Low Liquidity
As a micro-cap, the stock has very high volatility and wide spreads.

Competitors and Related Stocks (Beneficiaries)

The US pharmaceutical wholesale market is dominated by three players: Cencora (COR, formerly AmerisourceBergen), McKesson (MCK), and Cardinal Health (CAH). On the pharmacy and prescription management side, CVS Health (CVS) and Walgreens Boots Alliance (WBA) serve as reference points. WGRX is an ultra-small hybrid that combines an independent pharmacy + technology platform model, and is vastly different in scale from these giants.

Competitors
TickerCompanyPriceChangeMarket CapP/EPBRROEDividend Yield
CORCencora Inc$323.32-0.4%$61.7B24.020.2104.34%0.74%
MCKMckesson Corp$891.68+0.3%$104.0B23.9--0.37%
CAHCardinal Health Inc$240.00-0.2%$55.8B33.2--0.87%
CVSCVS Health Corp$95.38-0.7%$122.0B25.21.56.23%2.86%
Related stocks (beneficiaries)
TickerCompanyPriceChangeMarket CapP/EPBRROEDividend Yield
CORCencora Inc$323.32-0.4%$61.7B24.020.2104.34%0.74%
MCKMckesson Corp$891.68+0.3%$104.0B23.9--0.37%
CAHCardinal Health Inc$240.00-0.2%$55.8B33.2--0.87%
CVSCVS Health Corp$95.38-0.7%$122.0B25.21.56.23%2.86%

✅ Investor Checklist

WGRX is an ultra-small vertically integrated healthcare company combining wholesale, pharmacy, and technology. Before investing, review the items below.

ChecklistWhat to VerifyCurrent Status
🏥 Wholesale Revenue GrowthExpansion of independent pharmacy network and distribution scaleConfirm via quarterly results
💊 Technology Platform RevenueWhether PharmacyChain and SaaS revenue is actually being recognizedCheck 10-Q segment disclosure
📉 Narrowing Net LossesSpeed at which net losses shrink relative to revenueQuarterly income statement
💸 Cash and DilutionCash balance and funding-related disclosuresReview ad-hoc filings

Key risks include a margin disadvantage versus large wholesalers, delayed monetization of the technology business, dilution from repeated equity offerings, and price drawdowns if enthusiasm for the blockchain theme cools.

WGRX is an ultra-small healthcare holding company that combines wholesale, pharmacy, and blockchain technology. The vertically integrated model and tech theme are appealing, but execution and profitability risks make it a speculative name. Approach it with small position sizing and diversification, and review technology-platform revenue recognition and funding disclosures on a quarterly basis.

Check out Wellgistics Health's real-time quotes, technical indicators, and peer comparisons at a glance on US Stock Today's real-time dashboard.

Briefs · earnings · signals, first Subscribe
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →